Systematic review of neurocognition and occupational functioning in major depressive disorder

Neuropsychiatry

Volumn 3, Issue 1, 2013, Pages 97-105

  Evans, Vanessa C ^a   Chan, Sarah Sl ^a   Iverson, Grant L ^a   Bond, David J ^a   Yatham, Lakshmi N ^a   Lam, Raymond W ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL RESEARCH; COGNITION; COGNITIVE DEFECT; ECONOMIC ASPECT; EMPLOYMENT STATUS; FUNCTIONAL ASSESSMENT; FUNCTIONAL STATUS; HUMAN; MAJOR DEPRESSION; MEDICAL LITERATURE; NEUROPSYCHOLOGICAL TEST; OCCUPATIONAL DISEASE; OCCUPATIONAL PSYCHOLOGY; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; WORK CAPACITY;

EID: 84874094484     PISSN: 17582008     EISSN: 17582016     Source Type: Journal    
DOI: 10.2217/npy.13.3     Document Type: Review

References (59)

1. WHO. Annex Table 3: burden of disease in DALYs by cause, sex, and mortality stratum in WHO regions, estimates for 2002. In: The World Health Report 2004: Changing History. WHO, Geneva, Switzerland (2004).
2. Adler DA, Mclaughlin TJ, Rogers WH, Chang H, Lapitsky L, Lerner D. Job performance deficits due to depression. Am. J. Psychiatry 163(9), 1569-1576 (2006).
3. Kessler RC, Barber C, Birnbaum HG et al. Depression in the workplace: effects on short-term disability. Health Aff. (Millwood) 18(5), 163-171 (1999).
4. Druss BG, Rosenheck RA, Sledge WH. Health and disability costs of depressive illness in a major U.S. corporation. Am. J. Psychiatry 157(8), 1274-1278 (2000).
5. Goetzel RZ, Long SR, Ozminkowski RJ, Hawkins K, Wang S, Lynch W. Health, absence, disability, and presenteeism cost estimates of certain physical and mental health conditions affecting U.S. employers. J. Occup. Environ. Med. 46(4), 398-412 (2004).
6. Johnston K, Westerfield W, Momin S, Phillippi R, Naidoo A. The direct and indirect costs of employee depression, anxiety, and emotional disorders-an employer case study. J. Occup. Environ. Med. 51(5), 564-577 (2009).
7. Stewart WF, Ricci JA, Chee E, Hahn SR, Morganstein D. Cost of lost productive work time among US workers with depression. JAMA 289(23), 3135-3144 (2003).
8. Donaldson SI, Grant-Vallone EJ. Understanding self-report bias in organizational behavior research. J. Bus. Psychol. 17(2), 245-260 (2002).
9. Birnbaum HG, Kessler RC, Kelley D, BenHamadi R, Joish VN, Greenberg PE. Employer burden of mild, moderate, and severe major depressive disorder: mental health services utilization and costs, and work performance. Depress. Anxiety 27(1), 78-89 (2010).
10. Greer TL, Kurian BT, Trivedi MH. Defining and measuring functional recovery from depression. CNS Drugs 24(4), 267-284 (2010).
11. Lam RW, Filteau MJ, Milev R. Clinical effectiveness: the importance of psychosocial functioning outcomes. J. Affect. Disord. 132(Suppl. 1), S9-S13 (2011).
12. Lam RW, Michalak EE, Bond DJ, Tam EM, Axler A, Yatham LN. Which depressive symptoms and medication side effects are perceived by patients as interfering most with occupational functioning? Depress. Res. Treat. 2012, 630206 (2012).
13. Iverson GL, Brooks BL, Langenecker SA, Young AH. Identifying a cognitive impairment subgroup in adults with mood disorders. J. Affect. Disord. 132(3), 360-367 (2011).
14. Antikainen R, Hanninen T, Honkalampi K et al. Mood improvement reduces memory complaints in depressed patients. Eur. Arch. Psychiatry Clin. Neurosci. 251(1), 6-11 (2001).
15. Mowla A, Ashkani H, Ghanizadeh A, Dehbozorgi GR, Sabayan B, Chohedri AH. Do memory complaints represent impaired memory performance in patients with major depressive disorder? Depress. Anxiety 25(10), E92-E96 (2008).
16. Tsourtos G, Thompson JC, Stough C. Evidence of an early information processing speed deficit in unipolar major depression. Psychol. Med. 32(2), 259-265 (2002).
17. Landro NI, Stiles TC, Sletvold H. Neuropsychological function in nonpsychotic unipolar major depression. Neuropsychiatry Neuropsychol. Behav. Neurol. 14(4), 233-240 (2001).
18. Porter RJ, Gallagher P, Thompson JM, Young AH. Neurocognitive impairment in drug-free patients with major depressive disorder. Br. J. Psychiatry 182, 214-220 (2003).
19. Preiss M, Kucerova H, Lukavsky J, Stepankova H, Sos P, Kawaciukova R. Cognitive deficits in the euthymic phase of unipolar depression. Psychiatry Res. 169(3), 235-239 (2009).
20. Gohier B, Ferracci L, Surguladze SA et al. Cognitive inhibition and working memory in unipolar depression. J. Affect. Disord. 116(1-2), 100-105 (2009).
21. Henry J, Crawford JR. A meta-analytic review of verbal fluency deficits in depression. J. Clin. Exp. Neuropsychol. 27(1), 78-101 (2005).
22. Langenecker SA, Bieliauskas LA, Rapport LJ, Zubieta JK, Wilde EA, Berent S. Face emotion perception and executive functioning deficits in depression. J. Clin. Exp. Neuropsychol. 27(3), 320-333 (2005).
23. Langenecker SA, Caveney AF, Giordani B et al. The sensitivity and psychometric properties of a brief computer-based cognitive screening battery in a depression clinic. Psychiatry Res. 152(2-3), 143-154 (2007).
24. Baune BT, Miller R, Mcafoose J, Johnson M, Quirk F, Mitchell D. The role of cognitive impairment in general functioning in major depression. Psychiatry Res. 176(2-3), 183-189 (2010).
25. Randolph C. The Repeatable Battery for Neuropsychological Status. Harcourt Brace & Co., TX, USA (1999).
26. Godard J, Grondin S, Baruch P, Lafleur MF. Psychosocial and neurocognitive profiles in depressed patients with major depressive disorder and bipolar disorder. Psychiatry Res. 190(2-3), 244-252 (2011).
27. Delis DC, Kaplan E, Kramer JH. The Delis-Kaplan Executive Function System: Technical Manual. The Psychological Corporation, TX, USA (2001).
28. Laplante L, Baruch P. Manuel de CogitE II. Recherche Pragma Research, QC, Canada (1999).
29. Leon AC, Solomon DA, Mueller TI, Turvey CL, Endicott J, Keller MB. The range of impairment functioning tool (LIFERIFT): A brief measure of functional impairment. Psychol. Med. 29(4), 869-878 (1999).
30. Neu P, Bajbouj M, Schilling A, Godemann F, Berman RM, Schlattmann P. Cognitive function over the treatment course of depression in middle-aged patients: correlation with brain MRI signal hyperintensities. J. Psychiatr. Res. 39(2), 129-135 (2005).
31. Vythilingam M, Vermetten E, Anderson GM et al. Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment. Biol. Psychiatry 56(2), 101-112 (2004).
32. Wagner S, Doering B, Helmreich I, Lieb K, Tadic A. A meta-analysis of executive dysfunctions in unipolar major depressive disorder without psychotic symptoms and their changes during antidepressant treatment. Acta Psychiatr. Scand. 125(4), 281-292 (2012).
33. Wroolie TE, Williams KE, Keller J et al. Mood and neuropsychological changes in women with midlife depression treated with escitalopram. J. Clin. Psychopharmacol. 26(4), 361-366 (2006).
34. Hasselbalch BJ, Knorr U, Kessing LV. Cognitive impairment in the remitted state of unipolar depressive disorder: A systematic review. J. Affect. Disord. 134(1-3), 20-31 (2011).
35. Douglas KM, Porter RJ. Longitudinal assessment of neuropsychological function in major depression. Aust. NZ. J. Psychiatry 43(12), 1105-1117 (2009).
36. Frasch K, Bullacher C, Jager M et al. Effects of symptom reduction and psychotropic medication on cognitive impairment in depression. Psychopathology 42(1), 59-66 (2009).
37. Paelecke-Habermann Y, Pohl J, Leplow B. Attention and executive functions in remitted major depression patients. J. Affect. Disord. 89(1-3), 125-135 (2005).
38. Reppermund S, Ising M, Lucae S, Zihl J. Cognitive impairment in unipolar depression is persistent and non-specific: further evidence for the final common pathway disorder hypothesis. Psychol. Med. 39(4), 603-614 (2009).
39. Godard G, Baruch P, Grondin S, Lafleur MF. Psychosocial and neurocognitive functioning in unipolar and bipolar depression: A 12month prospective study. Psychiatry Res. 196, 145-153 (2012).
40. Grant MM, Thase ME, Sweeney JA. Cognitive disturbance in outpatient depressed younger adults: evidence of modest impairment. Biol. Psychiatry 50(1), 35-43 (2001).
41. Rohling ML, Green P, Allen LM 3rd, Iverson GL. Depressive symptoms and neurocognitive test scores in patients passing symptom validity tests. Arch. Clin. Neuropsychol. 17(3), 205-222 (2002).
42. Fossati P, Coyette F, Ergis AM, Allilaire JF. Influence of age and executive functioning on verbal memory of inpatients with depression. J. Affect. Disord. 68(2-3), 261-271 (2002).
43. Macqueen GM, Campbell S, McEwen BS et al. Course of illness, hippocampal function, and hippocampal volume in major depression. Proc. Natl Acad. Sci. USA 100(3), 1387-1392 (2003).
44. McClintock SM, Husain MM, Greer TL, Cullum CM. Association between depression severity and neurocognitive function in major depressive disorder: A review and synthesis. Neuropsychology 24(1), 9-34 (2010).
45. McDermott LM, Ebmeier KP. A meta-analysis of depression severity and cognitive function. J. Affect. Disord. 119(1-3), 1-8 (2009).
46. Tarbuck AF, Paykel ES. Effects of major depression on the cognitive function of younger and older subjects. Psychol. Med. 25(2), 285-295 (1995).
47. Prasad M, Wahlqvist P, Shikiar R, Shih YC. A review of self-report instruments measuring health-related work productivity: A patient-reported outcomes perspective. Pharmacoeconomics 22(4), 225-244 (2004).
48. Mattke S, Balakrishnan A, Bergamo G, Newberry SJ. A review of methods to measure health-related productivity loss. Am. J. Manag. Care 13(4), 211-217 (2007).
49. Abma FI, Van Der Klink JJ, Terwee CB, Amick BC 3rd, Bultmann U. Evaluation of the measurement properties of self-reported health-related work-functioning instruments among workers with common mental disorders. Scand J. Work Environ. Health 38(1), 5-18 (2012).
50. Brooks A, Hagen SE, Sathyanarayanan S, Schultz AB, Edington DW. Presenteeism: critical issues. J. Occup. Environ. Med. 52(11), 1055-1067 (2010).
51. Evans CJ. Health and work productivity assessment: state of the art or state of flux? J. Occup. Environ. Med. 46(Suppl. 6), S3-S11 (2004).
52. Kessler RC, Ames M, Hymel PA et al. Using the World Health Organization health and work performance questionnaire (HPQ) to evaluate the indirect workplace costs of illness. J. Occup. Environ. Med. 46(Suppl. 6), S23-S37 (2004).
53. Allen HM Jr, Bunn WB 3rd. Validating self-reported measures of productivity at work: A case for their credibility in a heavy manufacturing setting. J. Occup. Environ. Med. 45(9), 926-940 (2003).
54. Trivedi MH, Corey-Lisle PK, Guo Z et al. Remission, response without remission, and nonresponse in major depressive disorder: impact on functioning. Int. Clin. Psychopharmacol. 24(3), 133-138 (2009).
55. Dewa CS, Thompson AH, Jacobs P. The association of treatment of depressive episodes and work productivity. Can. J. Psychiatry 56(12), 743-750 (2011).
56. Wang PS, Simon GE, Avorn J et al. Telephone screening, outreach, and care management for depressed workers and impact on clinical and work productivity outcomes: A randomized controlled trial. JAMA 298(12), 1401-1411 (2007).
57. Connors K. Conner's CPT-II Continuous Performance Test II: Computer Program for Windows, Technical Guide and Software Manual. Multi-Health Systems Inc., CA, USA (2000).
58. Delis C, Kramer JH, Kaplan E, Ober BA. California Verbal Learning Test: Adult Version Manual (2nd Edition). The Psychological Corp., CA, USA (2000).
59. Chen HY, Dinmore A, Hildebrand D et al. Wechsler Abbreviated Scale of Intelligence Manual. The Psychological Corp., CA, USA (1999).